Playing the waiting game.

While no one is quite as good at it as the VA, rates of active surveillance and watchful waiting for low-risk prostate cancer are higher than ever according to the latest SEER analysis. In fact, it's now the most popular treatment of all. | Mahal, JAMA 2019